Medication info
Aldren Tablets 70mg (Sodium Alendronate Trihydrate)

Aldren Tablets 70mg (Sodium Alendronate Trihydrate)

Prescription medicationTabletOral
Ingredient · strength
Sodium Alendronate Trihydrate›91.37mg / 1 tablet
Manufacturer / importer
Korea Prime Pharmaceutical Co., Ltd.
Appearance
White oval tablet
Packaging
4 tablets (4 tablets / PTP packaging (AluAlu) x 1)
Approval status
Active

MFDS item code 200805740 · Notified 2008.05.22 · Insurance code 663602830

Summary

Main use
Treatment of osteoporosis in postmenopausal women and men
Who takes it
Adults
Adult dose
○ Take 70 mg of alendronic acid once weekly in the morning with a sufficient amount of water, at least 30 minutes before consuming food, beverages, or other medicines (see Precautions). ○ Other beverages or food, including mineral water and barley tea, and medicines may reduce the absorption of this medicine (see Drug Interactions). If food is consumed within 30 minutes after taking this medicine or at the same time, its absorption into the body may be reduced and its effect may decrease. Take this medicine immediately after getting up in the morning, swallowing it with a sufficient amount of water (170 ∼ 230 mL) to ensure rapid passage into the stomach and reduce the possibility of esophageal irritation. Do not lie down for at least 30 minutes after taking this medicine and until after the first food of the day. Do not take this medicine at bedtime or before getting up for the day. Failure to follow these instructions may increase the risk of esophageal adverse reactions (see Warnings and Precautions). Patients with insufficient dietary calcium and vitamin D intake should take supplements (see Precautions). ○ The appropriate duration of treatment has not been established. The safety and efficacy of this medicine for the treatment of osteoporosis are based on 4 years of clinical data. The need for continued treatment should be reassessed regularly in all patients receiving bisphosphonates. In patients at low risk of fracture, discontinuation should be considered after 3 ∼ 5 years of treatment. The risk of fracture should be reassessed regularly in patients who discontinue treatment. ○ If you forget to take a dose on the scheduled day, take 70 mg the next morning, then resume taking it on the originally scheduled day and continue taking it regularly once weekly thereafter. Do not take 2 tablets on the same day.

Ingredients

Manufacturer
Korea Prime Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of osteoporosis in postmenopausal women and men

  • Osteoporosis
View approved original text

This medication is used to treat osteoporosis in both postmenopausal women and men. Osteoporosis is a disease characterized by low bone density and increased fragility, which raises the risk of fractures. Therefore, this medication helps strengthen bones and prevent fractures. It is used for the treatment of osteoporosis in postmenopausal women and men.

How to take

Adult dose

○ Take 70 mg of alendronic acid once weekly in the morning with a sufficient amount of water, at least 30 minutes before consuming food, beverages, or other medicines (see Precautions). ○ Other beverages or food, including mineral water and barley tea, and medicines may reduce the absorption of this medicine (see Drug Interactions). If food is consumed within 30 minutes after taking this medicine or at the same time, its absorption into the body may be reduced and its effect may decrease. Take this medicine immediately after getting up in the morning, swallowing it with a sufficient amount of water (170 ∼ 230 mL) to ensure rapid passage into the stomach and reduce the possibility of esophageal irritation. Do not lie down for at least 30 minutes after taking this medicine and until after the first food of the day. Do not take this medicine at bedtime or before getting up for the day. Failure to follow these instructions may increase the risk of esophageal adverse reactions (see Warnings and Precautions). Patients with insufficient dietary calcium and vitamin D intake should take supplements (see Precautions). ○ The appropriate duration of treatment has not been established. The safety and efficacy of this medicine for the treatment of osteoporosis are based on 4 years of clinical data. The need for continued treatment should be reassessed regularly in all patients receiving bisphosphonates. In patients at low risk of fracture, discontinuation should be considered after 3 ∼ 5 years of treatment. The risk of fracture should be reassessed regularly in patients who discontinue treatment. ○ If you forget to take a dose on the scheduled day, take 70 mg the next morning, then resume taking it on the originally scheduled day and continue taking it regularly once weekly thereafter. Do not take 2 tablets on the same day.

Precautions

This medication may irritate the gastrointestinal mucosa, so patients with Barrett's esophagus, dysphagia, esophageal diseases, gastritis, duodenitis, ulcers, etc., need to be cautious when taking it. After taking it, side effects related to the esophagus such as esophagitis, esophageal ulcers, and esophageal erosion may occur, which in severe cases can progress to esophageal obstruction or perforation, so if symptoms occur, discontinue use immediately and consult a physician. When taking this medication, it should be taken with plenty of water, and the patient should not lie down for at least 30 minutes after taking it to reduce the risk of esophageal irritation. Patients with delayed esophageal motility, those who cannot sit or stand upright for 30 minutes or longer, patients allergic to this medication or its components, patients with hypocalcemia, severe renal failure, pregnant or nursing women, and those with certain genetic disorders should not take this medication. Long-term use of this medication can cause musculoskeletal pain or rarely serious side effects like jaw osteonecrosis, so if abnormal symptoms occur, consult medical personnel. Ensuring adequate intake of calcium and vitamin D while maintaining weight-bearing exercises and a healthy lifestyle is beneficial. There may be interactions with other medications, so when taking calcium supplements, antacids, aspirin, or non-steroidal anti-inflammatory drugs, it should be taken at intervals. It is safe for women who are pregnant or may become pregnant, and for nursing women, to avoid taking this medication. The safety for children and adolescents under 18 years has not been established, so it should not be used in this population. Elderly patients can take the medication, but some may be more sensitive to it, so caution is necessary. In case of overdose, symptoms of hypocalcemia and gastrointestinal side effects may occur, so contact medical personnel immediately and receive appropriate treatment. Inducing vomiting should be avoided, and the patient should be kept in an upright position. This medication should be stored out of reach of children, and it is advisable not to transfer it to other containers.

Side effects

Hemorrhage, esophagitis, esophageal ulcer, esophageal erosion, esophageal obstruction, esophageal perforation, dysphagia, odynophagia, retrosternal pain, heartburn, abdominal pain, nausea, dyspepsia, constipation, diarrhea, flatulence, acid reflux, vomiting, abdominal distension, gastritis, musculoskeletal pain, muscle cramps, headache, dizziness, altered taste, rash, erythema, anastomotic ulcer, urticaria, angioedema, hypersensitivity reaction, myalgia, lethargy, asthenia, fever, symptoms of hypocalcemia, peripheral edema, esophageal stricture, oropharyngeal ulcer, gastric ulcer, duodenal ulcer, localized osteonecrosis of the jaw, joint edema, femoral neck fracture, bone, joint and muscle pain, dizziness, itching, hair loss, mucocutaneous syndrome, toxic epidermal necrolysis, uveitis, scleritis, episcleritis, cholesteatoma of the external auditory canal

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture, ideally kept in a cool place between 15 and 30 degrees Celsius. Proper storage will help maintain the effectiveness of the medication and prevent deterioration.

Appearance and packaging

Appearance

White oval tablet

Package unit

4 tablets (4 tablets / PTP packaging (AluAlu) x 1)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.